Treating clinical supply as a late-stage fix creates delays, shortages, and cost overruns. Early planning—across DP availability, forecasting, QP release, labels, and IXRS—keeps trials on timeline and out of crisis.
- What 2025 FDA Warning Letters Tell Us About GMP Compliance
- Clinical Supply's Role In Driving Success In Decentralized Trials
- Phages As A Pharmaceutical: New EMA Guidance On Antimicrobial Drug Development
- On The Potency Assurance Journey, Travelers Need A Road Map
- Guidelines For Defining A Control Strategy Framework For Accelerated mAb Programs
- A Multi-Omics Approach For Characterizing Clinical-Scale iPSC Batches
- Global Implications Of Zero Tariffs On Indian Pharma Exports To China
- Why Do So Few Cell Therapies Make The Leap From Lab To GMP?
ON-DEMAND WEBINARS
This panel webinar discusses the importance of clinical supply agility and how to mitigate supply chain risk that comes along with clinical supply decisions.
In the era of seamless development, reducing time to the clinic and getting rapid approval is key. An integrated approach can accelerate timelines, avoid communication pitfalls, and improve outcomes.
If you are in the process of developing a complex or sensitive injectable drug, learn about containment solutions to mitigate your risks and help you get your drug to the patient faster.
Clinical supply innovators from across the industry share their experiences and lessons learned as they work to normalize the use of adherence measurement tools and smart medicine packages.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-980809416 clinical supply]( "Common RTSM/IRT AN Medication Pooling Questions Answered")
Common RTSM/IRT AN Medication Pooling Questions AnsweredWhether you’re planning a single trial or an entire program, medication pooling offers a pathway to cost-effective and sustainable clinical trial management.
-
![Medical-Research-laborratory-GettyImages-1354172439]( "Investigational Medicinal Products: Labeling Changes And Their Implications")
Investigational Medicinal Products: Labeling Changes And Their ImplicationsLearn about Annex VI, which covers changes in the labeling requirements for investigational medicinal products (IMPs) and harmonizes them throughout EU countries.
-
![iStock-486571129-supply-chain-logistics-packaging]( "Is Your Clinical Supply Strategy Ready For EU CTR?")
Is Your Clinical Supply Strategy Ready For EU CTR?One of the most significant changes in the new EU regulation is Annex VI, which covers changes in the labelling requirements for investigational medical products (IMPs). So, what are the implications of these changes and how will they affect outer immediate packaging?
-
![GettyImages-1293773576-lab-team-collaboration-planning-research]( "Overcoming Inventory Challenges For A Complex, Global Study")
Overcoming Inventory Challenges For A Complex, Global StudyExplore how the optimization of Interactive Response Technologies (IRT) settings relieved the burden of managing global supply needs for a CRO customer and clinical sponsor.
-
![Doctor Clinical Trial]( "IRT? RTSM? What's The Difference?")
IRT? RTSM? What's The Difference?What are the components of Randomization and Trial Supply Management (RTSM) and the critical role of RTSM and Interactive Response Technology (IRT) in clinical trials?
-
![GettyImages-1173740564 data management]( "Navigating Audit Trail Data Regulations And Accessibility Changes")
Navigating Audit Trail Data Regulations And Accessibility ChangesData is the single most important thing in a clinical trial. Leverage the power of clinical trial data with effective utilization and access in a changing regulatory landscape.
-
![GettyImages-1184502868 oncology patient]( "Emerging Biopharm Rapidly Sets Up Phase 1 Oncology Trial")
Emerging Biopharm Rapidly Sets Up Phase 1 Oncology TrialUncover how an emerging biopharmaceutical company was able to expedite the initiation of a Phase 1 oncology trial for a novel treatment targeting relapsed/refractory multiple myeloma.
-
![Supply Chain - Getty- 1159559071]( "Is Your Clinical Supply Chain Fully Optimized?")
Is Your Clinical Supply Chain Fully Optimized?Streamlined supply chain operations alleviate staff workload and significantly reduce IP waste. With the right partners, you can create a fully optimized, cost-effective supply chain strategy.
-
![West1]( "Prefillable Syringe Plungers: A Solution For Low Temperature Storage")
Prefillable Syringe Plungers: A Solution For Low Temperature StorageReview a study with 1 mL long glass and polymer-based syringes and with 2.25 mL glass syringes. Explore the impacts on plunger movement, container closure integrity, and break loose and extrusion force.
-
![GettyImages-980809416 clinical supply]( "Consolidating Clinical Supply Chain Operations With GxP Inventory")
Consolidating Clinical Supply Chain Operations With GxP InventoryA Japan-based biotechnology company leveraged Signant SmartSignals® GxP Inventory, which improved visibility, reduced risks and costs, and optimized operations in this case study.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
